The biological fitness of unicellular organisms is largely determined by their balanced growth rate, i.e., by the rate with which they replicate their biomass composition. Evolutionary optimization of this growth rate occurred under a set of physicochemical constraints, including mass conservation, reaction kinetics, and limits on dry mass per volume (cellular capacity). Mathematical models that account explicitly for these constraints are inevitably nonlinear, and their optimization has been restricted to small, non-realistic cell models. Here, we show that any balanced growth state can be represented as a weighted average of elementary flux modes (EFMs) of a corresponding flux balance problem, where maximal balanced growth under a single capacity constraint corresponds to a single EFM. For any balanced growth state that corresponds to an EFM of an arbitrarily sized model, we provide explicit expressions for individual protein concentrations, fluxes, and growth rate; all variables are uniquely determined by the concentrations of metabolites and total protein. We provide explicit and intuitively interpretable expressions for the marginal fitness costs and benefits of individual concentrations. At optimal balanced growth, the marginal net benefits of each metabolite concentration and of total protein concentration equal the marginal benefit of the cellular capacity. Based solely on physicochemical constraints, the balanced growth analysis (BGA) framework introduced here unveils fundamental quantitative principles of balanced cellular growth, quantifies the effect of cellular capacity on fitness, and leads to experimentally testable predictions.
I. INTRODUCTION
The defining feature of life is self-replication. For non-interacting unicellular organisms in constant environments, the rate of this self-replication is equivalent to their evolutionary fitness [1] : fast-growing cells outcompete those growing more slowly. Accordingly, natural selection has optimized the cellular composition of many microbes for maximal balanced growth rate in specific environments [2, 3] , i.e., for the fastest possible reproduction of all cellular components in proportion to their abundances [4] .
The variables of this evolutionary optimization are the abundances of the cellular metabolites and of the proteins and ribonucleic acids that catalyze their conversion into biomass. The corresponding boundary conditions are provided by the environment and by physicochemical constraints, including mass conservation, the kinetics of enzymatic and spontaneous reactions, and capacity constraints that limit cellular concentrations [3, [5] [6] [7] [8] .
Molenaar et al. [5] proposed a coarse-grained, mathematical model of balanced growth encapsulating the most important physicochemical constraints and the activity of up to seven biochemical reactions. Numerical optimization resulted in predictions that recovered qualitatively the growth-rate dependencies of cellular ribosome content, of cell size, and of the emergence of over- * Main text + SI † martin.lercher@hhu.de flow metabolism. Similar to other constraint-based approaches [9] [10] [11] , this modelling paradigm does not consider regulatory constraints, but instead assumes that protein regulation evolved to implement the optimal state. Due to the inclusion of non-linear enzyme kinetics, maximizing the growth rate is inevitably a non-linear optimization problem; this may explain why no attempts have been made to extend this approach to more detailed biochemical whole-cell models. Instead, "toy models" of 1-3 reactions were solved analytically to gain further qualitative understanding of systems-level effects, such as the increased cellular investment into ribosomes at faster growth [6] [7] [8] 12] and optimal gene regulation strategies [3, 7] .
Alternative modeling strategies, such as flux-balance analysis (FBA) [9, 13] , resource balance analysis (RBA) [10] , and ME (metabolism and expression) models [11] , can be viewed as simplifications of the balanced growth scheme [14] . These models are also based on the idea of growth rate optimization in a steady-state solution space defined by physicochemical and environmental constraints. However, they consider only linear constraints, and they ignore the influence of metabolite concentrations on reaction kinetics [9, 13] or approximate their effects through growth-rate dependent phenomenological scaling laws [10, 11, 15] . Fig. 1 shows a schematic comparison of FBA, which uses only linear constraints, and the Balanced Growth Analysis (BGA) for which we develop a theoretical framework below. In BGA, the external nutrient concentrations, reaction kinetics, and the requirement of balanced exponential growth under a capacity constraint define the system's solution space. Maximizing the growth rate over all permissible reactant and total protein concentrations results in quantitative predictions of reaction fluxes, protein expression, and biomass composition.
II. MODELS OF BALANCED EXPONENTIAL GROWTH
Our model assumes that in balanced growth, the cell increases exponentially in size, while the concentrations of all cellular components remain constant. In particular, we assume that the number of different membrane constituents per cell volume (and thus membrane composition and surface/volume ratio) remain constant in a given environment [5] . We do not explicitly model cell division; thus, our model can also be interpreted as describing the growth of a population of cells, with the simplifying assumption that individual cells have the same molecular composition [7] . To satisfy these assumptions, the net production rate of each molecular constituent must balance its dilution by growth,
where x denotes the concentration of a given component and µ is the cellular growth rate [7] . The mass conservation in chemical reaction networks such as in Fig. S4 is commonly described through a stoichiometric matrix N , where rows correspond to metabolites and each column describes the mass balance of one reaction, with negative entries for consumed and positive entries for produced metabolites [16] . Here, we will focus on matrices A that describe a network of active reactions, i.e., A is a sub-matrix of N that contains all columns j for reactions with flux v j = 0 and all rows for reactants i involved in these reactions either as substrates or as products (A also includes a "ribosome" reaction for protein production). Note that the activity of each reaction j in A implies a positive concentration p j > 0 for the protein catalyzing j; in our notation, catalytic proteins include not only enzymes, but also transporters and the ribosome.
For the development below, it will be convenient to express each concentration in units of mass concentration (mass per volume), which can be obtained from the corresponding number concentration by multiplying with the molecular mass. Accordingly, the entries of A are not stoichiometric coefficients but are mass fractions. We normalize the columns of A such that the negative entries (the mass concentration fraction consumed) sum to −1 and the positive entries (the mass concentration fraction produced) sum to +1; as we do not balance external concentrations, transport reactions do not have to be mass balanced, and thus one of these sums may have a smaller absolute value [16] .
The mass conservation of each component in an active reaction network can then be stated in matrix notation as
where a α is the mass concentration of reactant α and P is the total protein mass concentration, summed over all proteins j,
The first row of A describes the net production of total protein P , which is then distributed among the individual proteins j (each with concentration p j ); the remaining rows describe the net production of the reactants α.
In this formulation, we assume that proteins do only act as catalysts and not as substrates of reactions, and hence neither total protein nor individual proteins are considered "reactants".
The rate v j of a biochemical reaction j is the product of the concentration of its catalyzing protein p j and some kinetic function k j (a) that depends on the concentrations a α of active reactants,
We assume that the functional form of k j (a) and the (constant) kinetic parameters are known. −1 ). The final constraint considered here reflects the cellular requirement for a minimal amount of free water to facilitate diffusion [17, 18] . E. coli growth has been found to decrease when cellular free water content is reduced below standard conditions, eventually stopping altogether when free water disappears [18] . E. coli 's buoyant density [19] and cellular water content [18] appear to depend only on external osmolarity; at fixed external osmolarity, buoyant density remained constant even when experimenters induced drastic changes in cell mass and macromolecular composition [20] .
Accordingly, we assume here that the cellular dry weight per volume is limited to ρ, where ρ is determined by external osmolarity. We express this capacity constraint as
FIG. 1. A schematic comparison of flux balance analysis (FBA) and balanced growth analysis (BGA) for a simple toy model, where a nutrient G is taken up from the environment through a transporter t at rate vt and is then converted by an enzyme e with rate ve into a precursor for protein synthesis, AA. In FBA (top row), AA is assumed to be the biomass; in BGA, AA is converted further into protein P by a ribosome R; P represents the sum of all three proteins (t,e,R). More generally, FBA maximizes the production rate of a fixed biomass composition, constrained by mass balance and an upper limit on the transport flux. The predicted biomass production rate is linear in the transport flux. RBA maximizes the balanced reproduction of the cellular composition, constrained by mass balance (blue), non-linear reaction kinetics (red), and cellular capacity (grey). The growth rate predictions are a non-linear function of the transporter saturation.
For simplicity of notation, we use the following conventions: {α} is the set of all reactants in the active stoichiometric matrix A, and α indicates that we sum over all α ∈ {α}. We use corresponding notations for the sets of basis reactants {β} and dependent reactants {γ} (see below). For an overview over the symbols used in this manuscript, see Suppl. Table S2 .
Based on biophysical considerations, we might replace Eq. (6) with separate capacity constraints on the total volume concentration inside each cellular compartment [17] and on the total area occupied by non-lipid membrane components per membrane area [5, 21] . An even simpler capacity constraint imposed in most previous models [3, [5] [6] [7] [8] [10] [11] [12] is to fix total protein concentration P to a constant value. However, it has been shown that P decreases with increasing growth rate [20, 22] . Thus, while a constant P allows to simplify the presentation, Eq. (6) provides a more meaningful constraint; moreover, Eq. (6) allows us to determine the costs and benefits of varying the total protein concentration. T in two fundamentally different ways; below, we will exploit this fact to eliminate the flux variables and to derive explicit expressions for p j and for µ.
III. CELLULAR STATE DEFINED BY THE CONCENTRATION VARIABLES
Our first aim is to derive a simple mathematical description of the solution space of balanced growth. For any flux vector v and concentration vector x = [P, a] T that satisfy the mass balance Eq. (2) and the cellular capacity constraint Eq. (6), there exists a unique BGS v = λv with λ > 0 if all fluxes run in the direction compatible with the reaction kinetics (∀ j k j v j > 0), and no such BGS otherwise. Clearly, if k j v j ≤ 0, no solution with p j ≥ 0 exists. For k j = 0, the concentration of protein j is uniquely defined by p j = v j /k j (Eq. (4)). Let P = j v j /k j be the total protein concentration required for v . Then the only possibility to satisfy Eq. (3) is to set λ = P/P . Any weighted average of BGSs for the same concentration vector x = [P, a]
T is itself a BGS at these concentrations, with a growth rate that is the corresponding weighted average of growth rates. Let (v (1) , ..., v (n) ) be an ordered set of n BGSs at x with growth rates (µ (1) , ..., µ (n) ). Let v = i w i v (i) be any weighted average of these, with weights w i ≥ 0 and i w i = 1. The cellular capacity condition Eq. (6) depends only on x and is thus fulfilled also for the weighted average. The mass balance condition is linear in the fluxes and growth rates, and is hence also fulfilled for the weighted aver-ages of fluxes and growth rates. The protein concentrations of each BGS v (i) are p
To satisfy the reaction kinetics constraint Eq. (4), the protein concentrations of the weighted average are
i w i P = P , and thus v is a BGS.
For any BGS, we can define a corresponding linear (FBA-type) problem through the mass balance constraint Eq. (2) 
. Now normalize the weights by setting
is a weighted average of BGSs that differs from v by a constant factor, v = λv. As BGSs are uniquely defined by their direction, λ = 1 and v = v.
Thus, any BGS can be expressed as a weighted average over BGSs that are EFMs of the corresponding linear problem. The columns of the active matrix A of an EFM are linearly independent [25] , i.e., A has full column rank (SI VIII A; see also Ref. [24] ). Thus, without loss of generality, the derivations below assume that A has full column rank. In SI text VIII A, we use results on constrained FBA problems [26, 27] to show that any optimal BGS (i.e., a BGS with maximal growth rate µ) is an EFM of the corresponding linear problem (see also Ref. [24] ); thus, the results below apply directly to optimal BGSs.
In this section, we assume that the concentrations of total protein and of individual reactants, x := [P, a] are known, and derive the growth rate, fluxes, and concentrations of individual proteins from reaction kinetics and the requirement of balanced growth. We assume that the concentrations x obey the capacity constraint, but this constraint will only become important when we find the necessary conditions for optimal growth in Section V.
A may have more rows than columns, i.e., some metabolite concentrations are linearly dependent on the concentrations of other metabolites. These dependent concentrations are not free variables, and hence they can be put aside and dealt with separately. To do this, we decompose the linear system of equations represented by Eq. (2) into two parts, rearranging the rows of A into matrices B, C such that B contains the rows for the independent reactants. As A has full column rank, choosing linearly independent rows results in a square matrix B of full rank (#rows(B) = rank(B) = rank(A)). We thus write
where b is the vector of independent reactant concentrations, which correspond to the rows of B, and c is the vector of dependent reactant concentrations corresponding to the rows of C. B is identical to the reduced stoichiometric matrix in Ref. [28] . The relationship between A and B, C can be understood in terms of Matroid theory, where the rows of B form a basis for the matroid spanned by the rows of A, and the set of rows of C is the closure for the set of rows of B. If the choice for the partitioning of A into B and C is not unique, some partitionings may be pathological and should be avoided (SI text VIII B).
B is a square matrix of full rank, so there is always a unique inverse I := B −1 . Multiplying both sides of Eq. (7) by I from the left, we obtain
I ji quantifies the proportion of flux j invested into the dilution of component i, and we thus name I the investment (or dilution) matrix (see Fig. S4 for examples). In contrast to the stoichiometric matrix A, which describes local mass balances (Eq. (2)), I describes the structural allocation of reaction fluxes into the production of cellular components diluted by growth, and thus carries global, systems-level information. By substituting v in Eq. (8) with Eq. (9), we obtain
where we defined the dependence matrix D := CI. D describes the linear dependence of the dependent concentrations c on P and b; it is identical to the link matrix in Ref. [28] . When A is not square, B includes a proper subset of the rows in A, and thus B on its own is not mass balanced. The "missing" mass fluxes are balancing c, and hence the flux investment into c is already accounted for by Eq. (9) .
We are now in a position to express growth rate as an explicit function of the concentrations [P, a]
T . As k j (a) = 0, we can use the kinetic equations (4) to express the individual protein concentrations as p j = v j /k j (a). Inserting v j from the investment equation (9) gives
Substituting these expressions into the total protein sum, Eq. (3), we obtain
Below, we simplify the notation by writing k j := k j (a). Solving for µ results in the growth equation
Thus, if the active matrix A of a balanced growth state is full rank, there are unique and explicit mathematical solutions for p, v, and µ. In particular, this is the case for optimal states, as well as for all other states whose active matrix is the active matrix of an EFM for any constant biomass x. If all p j are positive (Eq. (11)), the corresponding cellular state is a balanced growth state; otherwise, no balanced growth is possible at these concentrations.
IV. MARGINAL FITNESS CONTRIBUTIONS OF CELLULAR CONCENTRATIONS
In biological systems, costs and benefits should be expressed in terms of fitness effects. In situations where fitness f is determined exclusively by growth rate, a small change in growth rate δµ translates into a corresponding change in relative fitness (SI text VIII C) of
Accordingly, we define the direct marginal net benefit η 0 i of the concentration x i with i ∈ {P, β} (i.e., x i ∈ {P, b β }) as the relative change in growth rate due to a small change in x i [29] ,
Also in this section, we do not use the constraint on cellular capacity (Eq. 6). While we (implicitly) assume that the original state before the change in x i respected the capacity constraint, we ignore the capacity constraint for the perturbed state in these definitions (i.e., we allow capacity to "adjust" to the change in x i and in any dependent concentrations c γ , if necessary). For i ∈ {P, β}, let us define
From the growth equation (13), it follows that
and
with
The summands in the denominator of the growth equation (13) can be expressed as p j /µ = v j /(µk j ) (Eq. (11)).
quantifies the proportional increase of p j to help offset the increased dilution of component i, and we thus call this the marginal (relative) production cost incurred by the system via protein p j . If I ji and k j are both positive, then q j i is also positive, i.e., it decreases fitness. The production costs are global, systems-level effects, quantified through the investment matrix I.
Conversely, u
quantifies the proportion of protein p j "saved" due to the change in kinetics associated with an increase in b β [30] . The benefit u j β will generally be positive if β is a substrate of reaction j. We thus call u j β the marginal (relative) kinetic benefit of reactant β to reaction j. The kinetic benefit is a purely local effect, as it is non-zero only for reactants that affect the kinetics of reaction j. Because fluxes are proportional to the concentrations of the proteins catalyzing the corresponding reactions, the marginal benefit of total protein in terms of relative fitness is simply P −1 . Combining the two relationships for production cost and kinetic benefit, we see that the direct net benefit is the reduction of the protein fraction p j /P at constant µ facilitated by the increase in x,
The definition of η 0 i (i ∈ {P, β}) accounts for the production costs of dependent reactants c γ (as these are embedded in I), but ignores their kinetic benefits. In analogy to Eq. (19), we define these as
with the marginal (relative) kinetic benefit of reactant γ to reaction j
We can now use the above relations to define the total marginal net benefit η i of concentration i ∈ {P, β} as the relative change in growth rate due to a small change in x i and the resulting change in the concentrations of its dependent reactants c γ ,
where the second equality follows from Eqs. (23), (10), (13) and definitions (21), (22) . A change δx i of x i (i ∈ {P, β}) causes a correlated change of each dependent concentration δc γ = D γi δx i (Eq. (10)). Thus, a change by δx i results in a total change of the utilization of cellular capacity by κ i δx i , with the capacity factor
V. OPTIMAL GROWTH AND THE BALANCE OF MARGINAL NET BENEFITS
At maximal growth rate, the cellular components will utilize the full cellular capacity ρ to saturate enzymes with their substrates, and thus the constraint in Eq. (6) will be active, that is, the inequality will become an equality.
To derive necessary conditions for any optimal balanced growth state at constant cellular capacity ρ, we use the method of Lagrange multipliers, which quantify the importance of the capacity constraint, Eq. (6), and of the constraints for the dependent reactants, Eq. (10), for the maximization of the objective function. The Lagrangian L is a function of P , a, and ρ (SI text VIII D).
Note that instead of using Lagrange multipliers, one could express the total protein concentration P = ρ − α a α (Eq. (6)) and the dependent reactant concentrations c γ = D γP P + β D γβ b β (Eq. (10)) in terms of ρ and of the independent reactant concentrations b. Substituting the resulting expressions in the growth equation (13) would result in an objective function that depends only on ρ and b, and that is constrained only by the requirement of positive concentrations. While this would lead to the same balance equations (26) as derived in the Lagrange multiplier framework, this formulation misses important insights that can be derived from the Lagrange multipliers themselves.
The maximal balanced growth rate µ * will be a function of the cellular capacity ρ. In analogy to the marginal net benefits of cellular components, we define the marginal benefit of the cellular capacity as the fitness increase facilitated by a small increase in ρ,
where the second equality follows from the envelope theorem [31] .
A necessary condition for optimal balanced growth is that all partial derivatives of L with respect to the concentrations (P, b β , c γ ) and to the Lagrange multipliers for ρ and for the individual dependent concentrations γ are zero. As detailed in SI text VIII D, this leads to the balance equations
The optimal state is perfectly balanced: the marginal net benefit of each independent cellular concentration x i equals the marginal benefit of the cellular capacity, scaled by κ i to account for its total utilization of cellular capacity. If i does not have any dependent reactants (26) states that if the dry weight density ρ would be allowed to increase by a small amount, such as 1µg/l, then the marginal fitness gain that could be achieved by increasing protein concentration (plus dependent concentrations) by this amount is identical to that achieved by increasing the concentration of any reactant β (plus its dependent concentrations) by the same amount. In hindsight, this should not be surprising: if the marginal net benefit of concentration x i (scaled by κ i ) was lower than that of x i , growth rate could be increased by increasing x i at the expense of x i .
Eq. (26) together with Eq. (6) describes a system of m + 2 equations for m + 2 unknowns (with m the number of basis reactants β; SI text VIII D). Any state of optimal growth must satisfy these equations. In realistic cellular systems, this set of equations has a finite number of discrete solutions. Thus, solving the non-linear optimization problem described by Eq. (2) and the corresponding constraints may potentially be accelerated by instead searching for the solution of the balance equations. If the optimization problem is convex, the conditions given by Eq. (26) are necessary and sufficient, and the solution is unique.
VI. QUANTITATIVE PREDICTIONS
A fully parameterized genome-scale balanced growth model may be used to predict all cellular concentrations at maximal growth rate. However, kinetic constants are currently lacking for many reactions even in the best studied model organisms [32] . We can still make quantitative predictions for the ribosome if we consider simplified models where the ribosome produces proteins from a single substrate, a generic ternary complex AA not consumed by other reactions (such as used in Ref. [33] and shown in Fig. S4A ). In the balance equation η 0 AA = η 0 P , the costs on both sides largely cancel each other, as all reactions that contribute directly or indirectly to AA production contribute proportionally to protein production. The only cost not cancelled is q R P = µ/(P k R ) (see, e.g., the balance equation for reactant "AA" in Fig.S4A ).
Thus, only the kinetics of the ribosome k R remain relevant, which we obtain from Ref. [33] . Using the mass balance of proteins, v R = µP , we thus predict the optimal protein fraction of actively translating ribosomes, φ R = p R /P , at each growth rate (SI text VIII E),
where r P is the mass fraction of the ribosome made up of protein, and k cat , K m are the kinetic parameters [33, 34] . [35, 36] , with a Pearson's correlation coefficient of R 2 = 0.96 (P = 2.4 × 10 −14 ) and geometric mean fold error = 1.09. The dashed grey line is the prediction using Eq. (S34) without production costs, which becomes a good approximation of Eq. (27) at lower growth rates (see also Ref. [37] ).
Despite the simplicity of this model, the predicted φ R is in good agreement with experimental values [35, 36] (Fig. S4D, solid red line ). An approximation that ignores the dilution of intermediates (production costs) and bases its predictions only on the capacity ρ (Fig. S4D , grey dashed line) results in less accurate predictions. However, this last approximation becomes better at lower growth rates, where the dilution of intermediates µa α becomes less and less important, and the optimal concentrations are increasingly determined by the capacity constraint. This finding explains why the assumption of a minimal utilization of cellular capacity by individual catalysts and their substrates provides a good approximation for the relationship between their concentrations [37] .
To get a rough quantitative estimate of the marginal net benefits η, let us consider the simplest model of a complete cell, consisting of only a transport protein and the ribosome [3, 6] (Suppl. Fig. VIII F) . Based on the experimentally observed protein fraction of total dry weight P/ρ = 0.54 in E. coli [18] , we estimate ρ η ρ = 0.69 (SI text VIII F). ρ η ρ quantifies the relative change in the maximal growth rate µ * resulting from a small, relative change in ρ. Thus, we estimate that a decrease in cellular dry weight density ρ of 1% would lead to a 0.69% decrease in growth rate, indicating that the capacity constraint is indeed highly biologically significant. ρ changes when external osmolarity is modified [18] .
ln ρ is the slope of the log-scale plot of µ vs. ρ at different external osmolarities. Increases in cellular dry weight density may have strong effects on diffusion and may hence change the kinetic constants. In contrast, reductions in ρ due to decreased external osmolarity are within the scope of our model, which assumes constant parameters for k(a). The very limited available experimental data (three data points from Ref. [38] , Fig. VIII F) suggests ρ η ρ ≈ 0.66, close to our rough estimate from the minimal cell model.
VII. CONCLUSIONS
Our derivations are based on the insight that for any balanced growth state that corresponds to an EFM of the corresponding linear (FBA) problem, the inverse I of the active stoichiometric matrix (or a basis thereof) contains global, systems-level information on the contribution of individual fluxes to the production of cellular constituents diluted by growth. Purely through structural constraints, this leads to an explicit dependence of reaction fluxes on the concentrations of the cellular constituents, scaled linearly by the growth rate (Eq. (9)). We combine this description with the complementary kinetic dependence of fluxes on concentrations. This allows us to provide explicit expressions for the individual protein concentrations p and fluxes v and for the growth rate µ as functions of arbitrary (positive) concentrations [P, b] T . These findings provide the framework from which we derive the balance equations for the marginal net benefits of cellular concentrations at optimal growth, and can be applied to general BGSs due to their composition as weighted averages of BGSs corresponding to EFMs.
Previous work has emphasized the central role of proteins in the cellular economy [3, [5] [6] [7] [8] [10] [11] [12] . Whereas total protein mass concentration in real biological systems is indeed much higher than the mass concentration of any other cellular constituent a α , the balance equations show that at optimal growth, their marginal net benefits are in fact equal, emphasizing the importance of explicitly accounting for all cellular constituents.
To make the presentation concise, our equations assume (i) that all proteins contribute to growth by acting as catalysts or transporters; (ii) that there is a 1-to-1 correspondence between proteins and reactions; (iii) that proteins are not used as reactants; and (iv) that all catalysts are proteins. It is straight-forward to remove these simplifications. E.g., assumption (i) can be removed by adding a sector of non-growth related proteins [15, 39] with concentration Q to the r.h.s. of Eq. (3); to remove assumption (iv), we can add different RNA species as cellular components and introduce reactions that combine proteins and RNA into molecular machines such as the ribosome.
An equation analogous to Eq. (9) can be formulated for non-growing cells (or cellular subsystems) that are instead optimized for the production of specific molecules, as is the case for many cell types in multicellular organisms. Instead of multiplying a dilution term, the production matrix I would then multiply a weighted production vector representing the desired output. The same strategy might be used to accelerate FBA solutions in a given EFM: FBA studies cellular growth, but assumes a fixed biomass composition [P, a] T . In principle, exploitation of the balance equations (Eq. (26)) may allow the numerical optimization even for cellular systems of realistic size, encompassing hundreds of protein and reactant species. One remaining obstacle to the accurate formulation of such models, though, is the current incompleteness of the kinetic constants needed to parametrize the functions k(a) [32] . The need for the development of high-throughput methods to systematically ascertain these parameters has been recognized [32] ; in the meantime, methods from artificial intelligence may provide reasonable approximations [40] .
As an alternative to genome-scale models, the balanced growth theory developed here could be applied to coarsegrained cellular models of increasing complexity, parameterized from experimental data. One would start from minimal models with two reactions [3, 6] , proceeding to models comprising the six previously described sectors of the cellular economy [39] and beyond [41] .
Our work extends the ad-hoc optimizations of toy models [3, [5] [6] [7] [8] into a full-fledged theory of balanced growth. We show that the balanced growth framework allows general, quantitative insights into cellular resource allocation and physiology, as exemplified by the growth and balance equations. Application and further development of this theory may foster an enhanced theoretical understanding of how physicochemical constraints determine the fitness costs and benefits of cellular organization. Moreover, the explicit expressions for the (marginal) costs and benefits of cellular concentrations in terms of fitness provide a rigorous framework for analyzing the cellular economy. We anticipate that this approach will prove fruitful in the interpretation of natural and laboratory evolution, and in optimizing the design of synthetic biological systems.
VIII. SUPPLEMENTARY MATERIAL
A. The active sub-network at maximal growth rate forms an elementary flux mode
Let N be a stoichiometric matrix of a general balanced growth model. Let A be a sub-matrix of N that contains only the columns for reactions that are active in a solution that maximizes the growth rate µ of the general problem, with corresponding active (nonzero) concentrations x = [P, a]
T . Let x * be the concentrations, v * the fluxes, k * = k(x * ) the values of the kinetic functions, and µ * the growth rate of the optimal solution. Then these values characterize also the optimal solution to the reduced balanced growth optimization problem, constrained by Eqs. (2), (3), (4), and (6) and summarized here: max µ subject to:
We now wish to relate the solution of this problem to elementary flux modes (EFMs) [23] , which are defined for the types of steady state models used in flux balance analysis (FBA) [9, 13] . We thus convert Eq. (S1) into a corresponding constrained FBA problem by treating the "biomass" vector x * of the optimal solution as a constant and by relaxing the equality constraint on the individual protein concentrations into an inequality constraint, P * ≥ j p j . With constant biomass x * , Eq. (2) is equivalent to the standard steady state constraint of flux balance analysis problems, formulated with an explicit balance equation for each biomass component rather than with a separate biomass reaction in A (see, for example, Eq. (2) in Ref. [42] ). With constant concentrations, total protein P * and the kinetic functions k * also become constant; the constraint relating to the cellular capacity (Eq. (6)) is trivially respected and can be ignored. Thus, the constrained FBA problem for the active stoichiometric matrix becomes: max λ subject to:
with biomass production rate λ and constant k * , P * , and biomass x * . This is precisely the type of constrained flux balance problem analyzed in Refs. [26, 27] , which prove that the solutions v opt to the optimization problem defined by Eq. (S2) are elementary flux modes (EFMs).
In the optimal solution to the problem defined by Eq. (S2), the protein concentration constraint will be active, that is, P * = j p j ; if not, the biomass production rate λ could be increased by multiplying the vector of protein concentrations p with a constant > 1 (as v j = p j k * j for all j). Thus, the optimization problem described by Eq. (S2) is the same as that described by Eq. (S1), except for a reduction in the dimension of the search space due to the fixed concentrations x * . Accordingly, the flux distribution v * that maximizes the balanced growth rate µ in Eq. (S1) also maximizes the biomass production rate λ of the FBA problem in Eq. (S2); it is hence an EFM of the active stoichiometric matrix A with biomass x * [26, 27] . Furthermore, it has been shown that the active stoichiometric matrix A of an EFM has full column rank (if A is formulated without an explicit "biomass" reaction) [25] . We conclude that the active stoichiometric matrix A of a balanced growth model at maximal growth rate has full column rank. Consequently, the corresponding basis matrix B is always invertible.
We emphasize that v * is an EFM of the constrained FBA problem in Eq. (S2), not of the balanced growth problem in Eq. (S1) from which it is derived. EFMs are defined as equivalence classes of minimal admissible steady-state flux distributions, whose members can be converted into each other by multiplication with a positive scalar [23] . This definition can not be generalized to balanced growth models, as multiples of an admissible flux vector generally do not satisfy Eq. (2) . For this reason, de Groot et al. have generalized the concept of EFMs to equivalence classes of minimal sets of active reactions in balanced growth states, termed elementary growth modes (EGMs) [24] . In parallel work to that presented here, these authors have shown that optimal solutions to balanced growth problems are EGMs, and that the active stoichiometric matrix of an EGM has full rank [24] .
If instead of a single constraint on cellular capacity, multiple capacity constraints are imposed simultaneously (e.g., to describe separate constraints on cytosolic and membrane capacities), then the solutions may instead correspond to convex combinations of EFMs of the related FBA problem [24, 43] ; this appears to be the case in overflow metabolism in E. coli [44] . In such cases, it is not guaranteed that A has full column rank, and generalizations of our theory may not be straightforward.
B. Choice of basis and relationship between capacity and dependence constraints
Not every reactant can be considered dependent: a reactant for which the corresponding row in the active matrix A is linearly independent of all other rows will always be in the basis (equivalently, a reactant that has zero entries in all vectors in a basis for the left null space of A cannot be a dependent reactant).
It is possible for some models that there is one or more choices of basis such that its corresponding dependence matrix has for some i ∈ {P, β}
In these cases, any marginal change in the mass concentration of component i will cause the exact opposite change in the total mass concentration of its dependent reactants γ. When this is combined with the capacity constraint as defined in Eq. (6), these changes in concentrations result in a perfect cancellation in the capacity utilized by i and its dependent reactants, and thus a zero net change in capacity for any change in the concentration i (i.e., κ i = 0 from Eq. (24)). For this reason, the marginal net benefit of i is simply η i = 0 (Eq. (26)). Such a perfect cancellation is highly unlikely if we use a more realistic description of the capacity constraint, where different cellular components i have different specific capacity utilizations σ i ; e.g., if we assume that the capacity constraint limits the total volume occupied by cellular components, then σ i gives the volume per mass of component i. In this case, the capacity constraint Eq. (6) is replaced by a constraint on the volume of cellular dry mass per volume of cell water, ν:
where σ P is the specific capacity of proteins (almost constant for different proteins [45] ) and σ α is the specific capacity of reactant α, which depends on its chemical properties such as hydrophobicity and charge [46] .
C. Definition of relative fitness
In a situation where competition among cells is solely through differential intrinsic growth rates, absolute fitness is equal to growth rate: In a population of cells growing exponentially with growth rate µ, the selection coefficient for a variant with growth rate µ + δµ is simply δµ [1] . Population genetics models almost always employ relative fitness [47] , which we here define as a relative growth rate:
Thus, to quantify the effect of a small change δx to some parameter x on relative fitness, we use
Note that population genetics models are frequently defined in terms of discrete generations. With generation time T = ln 2/µ, the selection coefficient of the variant per generation is then [48] 
D. Solution for the optimization problem using Lagrange multipliers
Our objective function is given by Eq. (13), which expresses µ as an explicit function of the concentrations [P, a]
T . The capacity constraint will be active at maximal growth rate, i.e., Eq. (6) becomes an equality. The capacity constraint can then be expressed as a function g ρ that also only depends on the concentrations,
Finally, the constraints on each dependent reactant γ also only depend on P, a, with the entries D γP determining the composition of each γ in terms of P , and D γβ determining the composition of γ in terms of b,
We are now able to define a Lagrange function as the sum of the objective function µ and the constraints g scaled by Lagrange multipliers,
The first order necessary conditions for a constrained local maximum are that all partial derivatives of L with respect to the variables P, b β , c γ and to the Lagrange multipliers λ ρ , λ γ are zero,
For the partial derivative with respect to an independent concentration x i (i ∈ {P, β}), we have
With Eq. (23), this results in
For the partial derivative relative to a dependent reactant γ , we have
With Eq. (21), we obtain
Substituting λ γ from Eq. (S15) into Eq. (S13) gives (for i ∈ {P, β})
Rearranging results in
where we used η ρ = −λ ρ /µ (Eq. (25)). We thus obtain the balance equation
for i ∈ {P, β}.
If neither P nor β have dependent concentrations (∀ γ D γP = 0 = D γβ ), Eq. (S18) results in the equality
In a regime where all reaction kinetics are much faster than the growth rate, k j µ, the production costs q j i are close to zero, and Eq. (S19) can be approximated by
Thus, in this regime, the marginal net benefits of reactants are determined only by their influence on kinetics, and dilution can be neglected. The second and third equation in Eq. (S11) simply enforce the constraints for the dependent reactants, Eq. (8), and for the cellular capacity, Eq. (6). Thus, the total number of equations is 1 (for ρ) + 1 (for P ) + #(independent reactants β) + #(dependent reactants γ) = m + 2, where m is the total number of reactants α. The number of unknowns is also m + 2 (m + 1 concentrations + η ρ ). To find the state of maximal balanced growth for a given system, it is more convenient to first consider only the m independent reactants β, and determine the dependent reactants γ later from Eq. (8) . In this case, Eq. (S18) and the constraint on cellular capacity Eq. (6) T and η ρ ). Fig. S4 shows two simple models of balanced cellular growth together with the corresponding matrices and balance equations. Fig. S4A shows a minimal model, where a transporter protein imports a nutrient (G), which is converted into precursors for proteins (AA) through an enzymatic reaction, and where the precursors are converted by a "ribosome" protein into the three proteins used as catalysts. Fig. S4B shows a slightly more involved model with cofactors.
E. Optimal ribosome protein fraction
Here we assume a very simple model for translation [33] . It accounts only for the elongation phase, where one catalyst (the ribosome plus bound mRNA, with concentration R) converts one substrate (the ternary complex, with concentration T ) into protein, following irreversible Michaelis-Menten kinetics (Eq. (5)). As further simplifications, we assume that the model has no dependent reactants (A = B) and that the ternary complex is not used in any other reaction. In this case, the same canceling of production costs as in the model depicted in Fig.S4A happens, and the balance of net benefits of ternary complex and total protein, η T = η P (Eq. (26)), simplifies to
Substituting the partial derivative of irreversible Michaelis-Menten kinetics (Eq. (5)), we obtain
where K m is the Michaelis constant of the ribosome for the ternary complex. Rearranging Eq. (5), we also see that the kinetics determine the concentration a T uniquely in terms of v R , R, K m , and the ribosome's turnover number k cat ,
Substituting this into Eq. (S22) gives
From the ribosome kinetics and mass conservation of proteins, we have
Thus, substituting µ/k R = R/P and v R = µP in Eq. (S24), we obtain
Solving for R/P gives
i.e., a quadratic equation in R/P . Its two solutions are
(S28) To see which of the two solutions is relevant, we rewrite this as
(S29) Because k cat R > R k R = v R = µP , the term in square brackets ([·]) in Eq. (S29) must be > 1. Only the positive root is compatible with this condition. Thus, the ratio R/P is uniquely determined by
(S30) To estimate the actual ribosome protein fraction of total protein φ R , we need to scale the previous expression by the fraction r P of ribosome which is protein, resulting in Eq. (27) .
The same procedure can be used to find an equation for φ R that ignores the production costs. Starting from Eq. (S24) without the production cost term µ/k R , we obtain
which results in a quadratic equation similar to Eq. (S27),
Again because Rk cat > µP , the term in parentheses (·) in Eq. (S33) must be > 1, and again only the positive root is compatible with this condition. Thus, the ribosome protein fractionis uniquely determined in this approximation by
We compared the predictions of the ribosome fraction of total protein, φ R = R/P , to quantitative proteomics data obtained by Schmidt et al. [35] . To obtain molar ribosome concentration, we calculated the median over all reported concentrations of ribosomal proteins. The concentration of ternary complexes was assumed to be identical to the concentration of their protein component, the elongation factor Tu. Molar concentrations of the ribosome and (total) ternary complexes were converted to mass concentrations by multiplying with molar masses derived from the amino acid sequences (for the protein parts) and nucleotide sequences (for the RNA parts). For this, we assumed that each ribosome contained one copy of each of its constituents, with the exception of four copies of RplL [49] . To calculate the mass fraction of total protein occupied by ribosomes, we multiplied ribosome mass concentrations with the mass fraction of ribosomes that is protein (r P = 0.58 [35] ), and divided the result by the total protein mass concentration P = 127.4 g/l in E. coli, assumed to be constant across growth conditions [35] .
The concentration of actively translating ribosomes was determined based on total ribosome concentration and the fraction of active ribosome at different growth rates. The latter was estimated by fitting a smooth saturation function s(µ) = µ/(µ + z) over the fractions of active ribosomes estimated in Ref. [36] , with the bestfitting parameter z = 0.124/h.
We set the Michaelis constant of the ribosome to K m = 3 × 10 −6 mol/l, based on the diffusion limit for ternary complexes calculated in Ref. [33] . We set the ribosome's turnover number to k cat = 22 AA/s, the highest elongation rate observed experimentally in Ref. [34] . As we do not distinguish between different ternary complexes and the ribosome only accepts one of the 40 different ternary complex types at any given time, K m was multiplied by 40 [33] . For consistency of the units with the mass concentration units used throughout our paper, the kinetic parameters had to be converted from molar to mass concentrations. The mean weight (± SD) of amino acids across all conditions assayed in Ref. [35] was 132.60 ± 0.09 Da; the ribosome molecular weight is 2, 306, 967 Da; and the mean weight of ternary complexes is 69, 167 ± 1, 351 g/mol. With these numbers, we obtain k cat = 22 AA/s × (132.60 Da/AA)/(2,306,967 Da) ×3, 600s/1h = 4.55/h, and K m = 40 × 3 × 10 −6 mol/l ×69, 167 g/mol = 8.30 g/l.
F. Minimal whole-cell model and the dependence of maximal growth rate on cellular water content Cayley et al. [18, 38] showed that the internal water content of E. coli cells increases when these are grown in environments with reduced osmolarity. This effect corresponds to a decrease of cellular dry weight per volume, ρ, by δρ. η ρ quantifies the associated reduction in relative fitness, δf = δµ * /µ * = η ρ δρ, with µ * the maximal growth rate (Eq. (25)). The relative change in the maximal growth rate as per relative change in ρ is then
From Eq. (26), we know that κ P η ρ = η P ; if there are no dependent reactants for P (i.e., ∀ γ D γP = 0), this simplifies to
and thus
The mass fraction of total protein in cell dry weight P/ρ has been shown to be approximately constant and equal to 0.54 across growth conditions that result in intermediate or high growth rates [18] . To estimate the total protein production cost j q j P , we consider the simplest possible whole-cell model, comprising only a transport reaction and the ribosome reaction (Fig.S1) . The active stoichiometric matrix A of this model and its inverse I = A −1 are
The capacity is determined only by its two components,
where
From the inverse I and Eq. (9), we obtain v t = µ(P + a) = µρ (S41)
From the inverse I and Eq. (4), we get
Combining this with Eq. (S41) and (S42) and with φ R = p R /P and φ t = p t /P = 1 − φ R results in
Combining this equation with Eq. (S37), we obtain
From Eq. (27), we estimate the mass fraction of ribosomal proteins in total protein φ R at µ = 1.0/h (growth rate in the reference growth condition of osmolarity Osm = 0.28 in Cayley et al. [38] ) to be φ R = 0.19. Substituting this value into Eq. (S45) together with P/ρ = 0.54, we estimate the relative change in the maximal growth rate per relative change in ρ as ρ η ρ = 0.69 .
Cayley et al. [38] report cell growth at reduced osmolarities, summarized in Table S1 . The cell free water content V f ree in Table S1 is calculated from the total cell water V cell minus the observed constant bound water V b = 0.40 ± 0.04 ml/gCDW [18] . Errors are estimated standard deviations based on error propagation among normally distributed random variables. Figure S2 plots the natural logarithms of µ and ρ. We estimate the slope of 0.66 at µ = 1.00/h with a linear regression over these points. This experimental value is close to our estimate of ρ η ρ = 0.69. TABLE S2 . Symbols and definitions. We note that for simplicity we also use P as an index for total protein, and ρ as an index for cellular dry weight per volume. 
